MedPath

A randomized controlled trial for directional penetration of traditional Chinese medicine combined with infrared ray in the treatment of diarrhea predominant irritable bowel syndrome with kidney yang deficiency syndrome

Phase 1
Conditions
irritable bowel syndrome
Registration Number
ITMCTR2000003695
Lead Sponsor
Shuguang Hospital Affiliated to Shanghai University of traditional Chinese Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

(1) No organic lesions were found by colonoscopy;
(2) Those who meet the diagnostic criteria of kidney yang deficiency syndrome;
(3) It was in accordance with the diagnostic criteria of Roman IV diarrhea predominant irritable bowel syndrome;
(4) Aged 18-70 years old;
(5) Informed consent and sign informed consent form.

Exclusion Criteria

(1) Patients with ulcerative colitis and other organic intestinal diseases;
(2) Severe primary diseases such as heart and brain, liver and kidney, blood system, etc;
(3) There are diseases that may affect intestinal function, such as diabetes, hyperthyroidism, inflammatory bowel disease, gastrointestinal cancer, intestinal infection, etc.
(4) Pregnant, lactating or planned pregnant women;
(5) Those who are allergic to the drugs used in this study or their ingredients;
(6) Mentally ill or unable to cooperate;
(7) There were severe blisters, blisters or skin lesions.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
IBS-QOL;The frequency and character of defecation per day;IBS.SSS;
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath